4/A//SEC Filing
FINCK BARBARA K 4/A
Accession 0001209191-22-029187
CIK 0001419041other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:58 PM ET
Size
6.0 KB
Accession
0001209191-22-029187
Insider Transaction Report
Form 4/AAmended
FINCK BARBARA K
Director
Transactions
- Award
Stock Option (right to buy)
2022-03-16+4,166→ 4,166 totalExercise: $1.43Exp: 2023-03-16→ Common Stock (4,166 underlying)
Footnotes (2)
- [F1]This amended Form 4 is being filed to report an option grant inadvertently omitted from the Form 4 filed on March 18, 2022.
- [F2]Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, the shares subject to the option shall vest in equal monthly installments over the twelve (12) months following the Date of Grant, provided that the shares subject to the option shall be fully vested on the date of the Issuer's next annual stockholder meeting. "Date of Grant" shall mean March 16, 2022.
Documents
Issuer
Forte Biosciences, Inc.
CIK 0001419041
Entity typeother
Related Parties
1- filerCIK 0001242116
Filing Metadata
- Form type
- 4/A
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:58 PM ET
- Size
- 6.0 KB